Share-based Payment Arrangement, Expense in USD of PSYCHEMEDICS CORP from 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PSYCHEMEDICS CORP quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2017 to Q4 2024.
  • PSYCHEMEDICS CORP Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2024 was $117K, a 37.4% decline year-over-year.
  • PSYCHEMEDICS CORP Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2024 was $917K, a 0.99% increase year-over-year.
  • PSYCHEMEDICS CORP annual Share-based Payment Arrangement, Expense for 2024 was $917K, a 0.99% increase from 2023.
  • PSYCHEMEDICS CORP annual Share-based Payment Arrangement, Expense for 2023 was $908K, a 4.13% increase from 2022.
  • PSYCHEMEDICS CORP annual Share-based Payment Arrangement, Expense for 2022 was $872K, a 17.4% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

PSYCHEMEDICS CORP Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $917K $117K -$70K -37.4% 01 Oct 2024 31 Dec 2024 10-K 24 Mar 2025
Q3 2024 $987K $228K -$173K -43.1% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $1.16M $275K +$132K +92.3% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 $1.03M $297K +$120K +67.8% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024
Q4 2023 $908K $187K +$9K +5.06% 01 Oct 2023 31 Dec 2023 10-K 24 Mar 2025
Q3 2023 $899K $401K +$124K +44.8% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $775K $143K -$95K -39.9% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 $870K $177K -$2K -1.12% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 $872K $178K -$1K -0.56% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $873K $277K +$99K +55.6% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 $774K $238K +$69K +40.8% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $705K $179K -$38K -17.5% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $743K $179K +$65K +57% 01 Oct 2021 31 Dec 2021 10-K 27 Mar 2023
Q3 2021 $678K $178K +$52K +41.3% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $626K $169K +$9K +5.63% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 $617K $217K +$54K +33.1% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q4 2020 $563K $114K -$136K -54.4% 01 Oct 2020 31 Dec 2020 10-K 27 Mar 2023
Q3 2020 $699K $126K -$64K -33.7% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 $763K $160K -$1K -0.62% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $764K $163K +$5K +3.17% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 $759K $250K 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2022
Q3 2019 $190K 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 $161K 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 $158K 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020

PSYCHEMEDICS CORP Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $917K +$9K +0.99% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025
2023 $908K +$36K +4.13% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025
2022 $872K +$129K +17.4% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $743K +$180K +32% 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2023
2020 $563K -$196K -25.8% 01 Jan 2020 31 Dec 2020 10-K 27 Mar 2023
2019 $759K +$165K +27.8% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2022
2018 $594K +$12K +2.06% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2021
2017 $582K 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.